Operating
Berkshire Hathaway·Cash Flow Statement·29 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | $13.6B | $1.8B | $4.6B | $10.9B | $10.1B | $13.8B | $11.2B | $10.4B |
| Net income | $30.5B | $26.5B | $19.8B | $4.7B | $12.5B | $30.9B | $19.3B | $10.2B |
| Depreciation and amortization | $3.2B | $3.2B | $3.3B | $3.3B | $3.3B | $3.3B | $3.5B | $3.5B |
| Change in receivables | $1.6B | $602M | -$2.4B | $3.3B | $939M | $1.7B | — | $3.2B |
| Amortization of Investment Discount and Premium | $2.6B | $3.4B | $3.5B | $3.1B | $3B | $2.7B | $3.1B | $3.1B |
| Accretion (amortization) of discounts and premiums on investments | $2.6B | $3.4B | $3.5B | $3.1B | $3B | $2.7B | $3.1B | $3.1B |
| Accretion (Amortization) of Investment Discounts and Premiums | $2.6B | $3.4B | $3.5B | $3.1B | $3B | $2.7B | $3.1B | $3.1B |
| Accretion (Amortization) of Discounts and Premiums, Investments | $2.6B | $3.4B | $3.5B | $3.1B | $3B | $2.7B | $3.1B | $3.1B |
| Accretion (Amortization) of Investment Discounts and Premiums | $2.6B | $3.4B | $3.5B | $3.1B | $3B | $2.7B | $3.1B | $3.1B |
| Gain (Loss) on Investments | $23.9B | $20.5B | $6.6B | -$6.4B | $6.4B | $21.9B | $17.2B | -$1.6B |
| Change in income taxes payable/receivable | $5.7B | -$9.3B | -$7B | $204M | -$3.2B | $4.2B | — | $1.5B |
| Unearned premiums | $241M | $775M | — | $1.5B | $61M | $1.1B | — | $1.4B |
| Increase (Decrease) in Other Operating Assets | $421M | $713M | — | $297M | $443M | $0 | $185M | $1.4B |
| Change in other liabilities | — | — | -$559M | -$1.3B | — | $1.6B | — | -$988M |
| Other non-cash income (expense) | $44M | -$1.7B | $1.6B | -$1.5B | -$6.3B | — | — | -$277M |
| Other Non-Cash Income (Expense) | $44M | -$1.7B | $1.6B | -$1.5B | -$6.3B | — | — | -$277M |
| Other Non-cash Income (Expense) | $44M | -$1.7B | $1.6B | -$1.5B | -$6.3B | — | — | -$277M |
| Other Non-cash Income (Expense) | $44M | -$1.7B | $1.6B | -$1.5B | -$6.3B | — | — | -$277M |
| Other non-cash income (expense) | $44M | -$1.7B | $1.6B | -$1.5B | -$6.3B | — | — | -$277M |
| Other Noncash Income (Expense) | $44M | -$1.7B | $1.6B | -$1.5B | -$6.3B | — | — | -$277M |
| Other Non-cash Income and Expense | $44M | -$1.7B | $1.6B | -$1.5B | -$6.3B | — | — | -$277M |
| Other Non-Cash Adjustments | $44M | -$1.7B | $1.6B | -$1.5B | -$6.3B | — | — | -$277M |
| Other Non-Cash Income and Expense | $44M | -$1.7B | $1.6B | -$1.5B | -$6.3B | — | — | -$277M |
| Increase Decrease In Deferred Charges Retroactive Reinsurance | -$254M | -$179M | -$88M | -$169M | -$154M | -$176M | -$194M | -$252M |
| Unpaid losses and loss expenses | $573M | $2.2B | — | $1.2B | $929M | $445M | $499M | $223M |
| Other-Than-Temporary Impairment Losses on Investments | — | — | — | $2.7B | $2.7B | $2.7B | $2.7B | — |
| Equity Method Investment Impairment | — | — | — | $2.7B | $2.7B | $2.7B | $2.7B | — |
| Impairment charges | — | — | — | $2.7B | $2.7B | $2.7B | $2.7B | — |
| Impairment on Equity Investment | — | — | — | $2.7B | $2.7B | $2.7B | $2.7B | — |